Table 1 Baseline characteristics of each illness category.
Asymptomatic | Acute COVID-19 (≤ 7 days) | Ongoing Symptomatic COVID-19 (28–83 days) | Post COVID-19 Syndrome (≥ 84 days) | Non-COVID-19 illness (28–83 days) | Non-COVID-19 illness (≥ 84 days) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Col % | n | Col % | n | Col % | n | Col % | n | Col % | n | Col % | |
Total | 307 | 1147 | 652 | 180 | 239 | 48 | ||||||
Age (mean, sd) | 58.1 | (10.2) | 53.2 | (12.0) | 53.1 | (11.2) | 53.6 | (11.5) | 53.7 | (11.0) | 58.1 | (9.2) |
Age Groups | ||||||||||||
< 30 | 5 | 1.6% | 41 | 3.6% | 19 | 2.9% | 7 | 3.9% | 5 | 2.1% | 0 | 0.0% |
30–39 | 9 | 2.9% | 130 | 11.3% | 65 | 10.0% | 16 | 8.9% | 26 | 10.9% | 1 | 2.1% |
40–49 | 47 | 15.3% | 219 | 19.1% | 133 | 20.4% | 36 | 20.0% | 42 | 17.6% | 7 | 14.6% |
50–59 | 92 | 30.0% | 401 | 35.0% | 247 | 37.9% | 67 | 37.2% | 88 | 36.8% | 18 | 37.5% |
60–69 | 122 | 39.7% | 259 | 22.6% | 151 | 23.2% | 41 | 22.8% | 63 | 26.4% | 17 | 35.4% |
70 + | 32 | 10.4% | 95 | 8.3% | 37 | 5.7% | 13 | 7.2% | 14 | 5.9% | 5 | 10.4% |
Sex | ||||||||||||
Male | 68 | 22.1% | 251 | 21.9% | 144 | 22.1% | 35 | 19.4% | 39 | 16.3% | 12 | 25.0% |
Female | 238 | 77.5% | 892 | 77.8% | 505 | 77.5% | 141 | 78.3% | 200 | 83.7% | 36 | 75.0% |
Other/PFNTS | 1 | 0.3% | 4 | 0.3% | 3 | 0.5% | 4 | 2.2% | 0 | 0.0% | 0 | 0.0% |
BMI (median, IQR) | 25.3 | (25.6–28.4) | 25.2 | (22.7–28.6) | 25.5 | (22.9–29.4) | 26.3 | (23.4–31.9) | 25.7 | (22.7–30.3) | 26.2 | (22.5–29.7) |
< 18.5 | 1 | 0.3% | 10 | 0.9% | 5 | 0.8% | 5 | 2.8% | 6 | 2.5% | 1 | 2.1% |
18.5–24.9 | 141 | 45.9% | 547 | 47.7% | 287 | 44.0% | 59 | 32.8% | 103 | 43.1% | 18 | 37.5% |
25–29.9 | 111 | 36.2% | 369 | 32.2% | 210 | 32.2% | 62 | 34.4% | 65 | 27.2% | 18 | 37.5% |
30.0–34.9 | 36 | 11.7% | 139 | 12.1% | 95 | 14.6% | 33 | 18.3% | 42 | 17.6% | 7 | 14.6% |
35 + | 13 | 4.2% | 75 | 6.5% | 49 | 7.5% | 21 | 11.7% | 21 | 8.8% | 4 | 8.3% |
Missing | 5 | 1.6% | 7 | 0.6% | 6 | 0.9% | 0 | 0.0% | 2 | 0.8% | 0 | 0.0% |
Confirmed by Swab Test at symptom onset (n, %) | 15 | 4.9% | 567 | 49.4% | 315 | 48.3% | 84 | 46.7% | 163 | 68.2% | 28 | 58.3% |